ConductScience.org, home

Paper39746751

RNA editing in disease: mechanisms and therapeutic potential.

Tamizkar KH and 1 other. RNA, 2025. Cited by 9 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. RNA editing in disease: mechanisms and therapeutic potential. Papers, record 39746751. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39746751

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
RNA editing in disease: mechanisms and therapeutic potential.
PubMed
Journal
RNA
PubMed
Year
2025
PubMed
Publication types
Journal Article, Review, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
9
iCite
Relative citation ratio, by iCite
2.17, provisional
iCite
Revised in PubMed
2026-03-25
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Tamizkar KHKasra Honarmand
2Jantsch MFMichael Fhttps://orcid.org/0000-0003-1747-0853

Source PubMed

Download CSV of authors

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
RNA EditingMajor topic
Humans
Adenosine Deaminase
Inosine
Adenosine
Animals

References106

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
125456137The RNA-editing enzyme ADAR1 controls innate immune responses to RNA.Cell Rep2014https://conductscience.org/library/papers/25456137PubMed
234569891Site-directed RNA editing: recent advances and open challenges.RNA Biol2021https://conductscience.org/library/papers/34569891PubMed
310438602The importance of internal loops within RNA substrates of ADAR1.J Mol Biol1999https://conductscience.org/library/papers/10438602PubMed
435850307RNA binding by ADAR3 inhibits adenosine-to-inosine editing and promotes expression of immune response protein MAVS.J Biol Chem2022https://conductscience.org/library/papers/35850307PubMed
538128529Disrupted RNA editing in beta cells mimics early-stage type 1 diabetes.Cell Metab2024https://conductscience.org/library/papers/38128529PubMed
62434241A developmentally regulated activity that unwinds RNA duplexes.Cell1987https://conductscience.org/library/papers/2434241PubMed
731772029Cardiac valve involvement in ADAR-related type I interferonopathy.J Med Genet2020https://conductscience.org/library/papers/31772029PubMed
835859175ADAR1 prevents autoinflammation by suppressing spontaneous ZBP1 activation.Nature2022https://conductscience.org/library/papers/35859175PubMed
92704740A double-stranded RNA unwinding activity introduces structural alterations by means of adenosine to inosine conversions in mammalian cells and Xenopus eggs.Proc Natl Acad Sci U S A1989https://conductscience.org/library/papers/2704740PubMed
1030849393ADAR1: A New Target for Immuno-oncology Therapy.Mol Cell2019https://conductscience.org/library/papers/30849393PubMed
1128388405Trade-off between Transcriptome Plasticity and Genome Evolution in Cephalopods.Cell2017https://conductscience.org/library/papers/28388405PubMed
1225555396Dynamic response of RNA editing to temperature in Drosophila.BMC Biol2015https://conductscience.org/library/papers/25555396PubMed
1327643693Neurologic Phenotypes Associated with Mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, ADAR1, and IFIH1: Aicardi-Goutières Syndrome and Beyond.Neuropediatrics2016https://conductscience.org/library/papers/27643693PubMed
1411041852Double-stranded RNA adenosine deaminases ADAR1 and ADAR2 have overlapping specificities.Biochemistry2000https://conductscience.org/library/papers/11041852PubMed
1510698941RNA recognition by a Staufen double-stranded RNA-binding domain.EMBO J2000https://conductscience.org/library/papers/10698941PubMed
1635145313Engineered circular ADAR-recruiting RNAs increase the efficiency and fidelity of RNA editing in vitro and in vivo.Nat Biotechnol2022https://conductscience.org/library/papers/35145313PubMed
1723001123Mutations in ADAR1 cause Aicardi-Goutières syndrome associated with a type I interferon signature.Nat Genet2012https://conductscience.org/library/papers/23001123PubMed
1814615479Liver disintegration in the mouse embryo caused by deficiency in the RNA-editing enzyme ADAR1.J Biol Chem2004https://conductscience.org/library/papers/14615479PubMed
1936457700Filamin A pre-mRNA editing modulates vascularization and tumor growth.Mol Ther Nucleic Acids2022https://conductscience.org/library/papers/36457700PubMed
2027595325Adenosine-to-inosine RNA editing controls cathepsin S expression in atherosclerosis by enabling HuR-mediated post-transcriptional regulation.Nat Med2016https://conductscience.org/library/papers/27595325PubMed

See all 106 referencesDownload CSV of references

Cited by9

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 9 citations.

PMIDTitleJournalYearIn PapersSource
42548802ADAR1 regulates radiosensitivity in ESCC through cIAP2-NF-κB signaling and C16orf46 editing.iScience2026https://conductscience.org/library/papers/42548802PubMed
42328436RNA variation as the driver of genomic efficiency and phenotypic complexity.Int J Biol Sci2026https://conductscience.org/library/papers/42328436PubMed
42310695A cytoplasmic index for quantifying immune-related A-to-I RNA editing.Genome Biol2026https://conductscience.org/library/papers/42310695PubMed
42222368RNA editing in Parkinson's disease: emerging mechanisms, translational potential, and current challenges.Front Neurosci2026https://conductscience.org/library/papers/42222368PubMed
41742325Stunning Intricacies of RNA Editing Complexes RECC, RESC, and REH2C: Functional Organization, Developmental Regulation, and Evolutionary History in Kinetoplastid Protists.Wiley Interdiscip Rev RNA2026https://conductscience.org/library/papers/41742325PubMed
41090155Gene and RNA Editing: Revolutionary Approaches to Treating Diseases.MedComm (2020)2025https://conductscience.org/library/papers/41090155PubMed
41075184Cromolyn as a novel pharmacophore of the Zα domain of the RNA-editing enzyme ADAR1p150.Protein Sci2025https://conductscience.org/library/papers/41075184PubMed
40671518ADARs: pleiotropy in function, versatility in application.Nucleic Acids Res2025https://conductscience.org/library/papers/40671518PubMed
39858624ADAR Therapeutics as a New Tool for Personalized Medicine.Genes (Basel)2025https://conductscience.org/library/papers/39858624PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39746751

GET https://conductscience.org/api/papers/v1/39746751/references?page=2